Skip to main content
Fig. 4 | Annals of Clinical Microbiology and Antimicrobials

Fig. 4

From: A combination of silver nanoparticles and visible blue light enhances the antibacterial efficacy of ineffective antibiotics against methicillin-resistant Staphylococcus aureus (MRSA)

Fig. 4

Combination of AgNPs, blue light, and clarithromycin against two isolates of MRSA. The triple combination of AgNPs with the blue light and clarithromycin against two isolates of MRSA was assessed. The isolates were selected on the basis of synergistic response in checkerboard assay. Based on the best result of the combination in the checkerboard assay, the concentrations of the two agents were used as follow: a Isolate C51: AgNPs at 1/8 of the MIC, and azithromycin at 0.25 µg/mL. b Isolate C41: AgNPs at 1/512 of the MIC, and azithromycin at 0.25 µg/mL. AgNPs silver nanoparticles, CFU colony forming unit, CLR clarithromycin, SD standard deviation

Back to article page

Annals of Clinical Microbiology and Antimicrobials

ISSN: 1476-0711

Contact us